[Diagnosis and treatment of pediatric acute lymphoblastic leukemia: Historical review].
Valdez-Garibay B, Sosa-Bustamante GP, González AP, Linares-Segovia B, Martínez-Villegas O, Reyes-Sosa AM, Paque-Bautista C.
Rev Med Inst Mex Seguro Soc. 2025 Jul 1;63(4):e6552. doi: 10.5281/zenodo.15644329.
Biological drug and drug delivery-mediated immunotherapy.
Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W.
Acta Pharm Sin B. 2021 Apr;11(4):941-960. doi: 10.1016/j.apsb.2020.12.018. Epub 2020 Dec 31.
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW.
Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10.
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.
Kumar AR, Devan AR, Nair B, Vinod BS, Nath LR.
Mol Biol Rep. 2021 Dec;48(12):8075-8095. doi: 10.1007/s11033-021-06752-9. Epub 2021 Oct 20.
Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
Ruan Y, Xie L, Zou A.
J Cancer Res Clin Oncol. 2023 Sep;149(12):10841-10850. doi: 10.1007/s00432-023-04974-x. Epub 2023 Jun 14.
Evaluation of biomarkers for intestinal damage in pediatric acute lymphoblastic leukemia.
Kairiene I, Tarutyte G, Vaisnore R, Kaminskas A, Petrenas T, Songailiene J, Eidukaite A, Gorbikova E, Rascon J.
Sci Rep. 2025 May 15;15(1):16899. doi: 10.1038/s41598-025-98947-4.
Detection of acute lymphoblastic leukemia using image segmentation and data mining algorithms.
Acharya V, Kumar P.
Med Biol Eng Comput. 2019 Aug;57(8):1783-1811. doi: 10.1007/s11517-019-01984-1. Epub 2019 Jun 14.
Adipocytes Impair Mitoxantrone Cytotoxicity Against Acute Lymphoblastic Leukemia.
Cohen M, Orgel E, Nevarez-Mejia J, Chen T, Neely M, Louie S, Mittelman SD.
EJHaem. 2025 Aug 30;6(5):e70140. doi: 10.1002/jha2.70140. eCollection 2025 Oct.
Quantitative acute leukemia cytogenetics.
Mitelman F, Heim S.
Genes Chromosomes Cancer. 1992 Jul;5(1):57-66. doi: 10.1002/gcc.2870050109.
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells.
Liu L, Chen J, Bae J, Li H, Sun Z, Moore C, Hsu E, Han C, Qiao J, Fu YX.
Nat Biomed Eng. 2021 Nov;5(11):1261-1273. doi: 10.1038/s41551-021-00800-2. Epub 2021 Nov 1.
